LINC-ROR and breast cancer: Inhibition of lincRNA-ROR also increases the sensitivity of BC cells to 5-Fluorouracil (5-FU) and paclitaxel by upregulating E-cadherin expression and downregulating Vimentin and N-cadherin expression.